University College Dublin

While the GLP-1 agonists have been hailed for their double-digit percentage weight reductions in clinical trials presented at the recent American Diabetes Association (ADA) annual meeting, data on how

IN VITRO DIAGNOSTICS Clinical Genomics Technologies Pty. Ltd. Clinical Genomics raises $15mm through Series A round Clinical Genomics Technologies Pty. Ltd. raised $15mm through a Series A rou

In Vitro Diagnostics Biocartis SA Series C generates €71mm for Biocartis Four-year-old Swiss molecular diagnostics company Biocartis NV has raised €71mm ($96mm) in its Series C financing led by

Medical Device Transactions The medical device community raised $906 million in the third quarter of 2011 (s ee Exhibit 1 ), a 47% slump from the second quarter’s $1.7 billion, which had featured seve